Clinical and immunological findings in large B-cell chronic lymphocytic leukemia

Clin Immunol Immunopathol. 1988 Feb;46(2):177-85. doi: 10.1016/0090-1229(88)90180-8.

Abstract

In order to define the characteristics of B-CLL cases in which the predominant cell population is composed of large lymphocytes, we studied 97 patients with B-CLL, comparing the cell morphological features with the clinical and biological findings and the immunological phenotype of the proliferating cells. Multivariant analysis showed that there were three significantly different morphological groups: Typical CLL, large lymphocyte CLL (LLL), and CLL with prolymphocytes (CLL/PL). The LLL group showed a greater incidence of lymphadenopathies (P less than 0.05) and higher percentages of both mu + delta + cells (P less than 0.01) and Fmc/7+ cells (P less than 0.001) than in typical CLL. The main differences between LLL and CLL/PL were the peripheral blood lymphocyte count and the percentage of Fmc/7+ cells (P less than 0.002)--both higher in the CLL/PL group--and the percentage of mouse rosette-forming cells (P less than 0.01)--lower in CLL/PL. Further studies including functional assays and survival analyses could contribute to elucidating whether these groups are different entities or a single disease with marked heterogeneity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Antigens, Differentiation / analysis
  • Antigens, Neoplasm / analysis
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology*
  • B-Lymphocytes / physiopathology
  • Humans
  • Leukemia, Lymphoid / classification*
  • Leukemia, Lymphoid / pathology
  • Leukemia, Lymphoid / physiopathology
  • Lymph Nodes / pathology
  • Spleen / pathology

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation
  • Antigens, Neoplasm